Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma

Virchows Archiv

Volumn 451, Issue 1, 2007, Pages 65-71

  Soares, A B ^a   Juliano, P B ^a   Araujo, V C ^b   Metze, K ^a   Altemani, A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

Angiogenesis; Carcinoma; Malignant transformation; Pleomorphic adenoma

Indexed keywords

CD34 ANTIGEN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CARCINOMA; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PLEOMORPHIC ADENOMA; VASCULARIZATION;

ADENOMA, PLEOMORPHIC; AGED; ANTIGENS, CD; ANTIGENS, CD34; CARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE;

EID: 35748970772     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-007-0438-z     Document Type: Article

References (30)

1. Akagi K, Ikeda Y, Sumiyoshi Y, Kimura Y, Kinoshita J, Miyazaki M, Abe T (2002) Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery 131:109-113
2. Altemani A, Martins MT, Freitas L, Soares F, Araújo NS, Araújo VC (2005) Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 46:635-641 (Pubitemid 40834822)
3. Ding S, Li C, Lin S, Yang Y, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesion. Human Pathol 37:861-866 (Pubitemid 43902946)
4. Diodoro MG, Di Carlo E, Zappacosta R, Iezzi M, Coletti A, Modesti A, D'Antuono T, Forni G, Musiani P (2000) Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. Int J Cancer 88:329-335
5. Doi R, Kuratate I, Okamoto E, Ryoke K, Ito H (1999) Expression of p53 oncoprotein increase intratumoral microvessel formation in human salivary gland carcinomas. J Oral Pathol Med 28:259-263 (Pubitemid 29298249)
6. Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:948-992
7. Ellis GL, Auclair PL (1996) Malignant epithelial tumors. In: Rosai J, Sobin LH (eds) Atlas of tumor pathology, series 3, section 5, fascicle 17. Armed Forces Institute of Pathology, Washington, DC, pp 155-373
8. Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M (2003) Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets 3:427-432 (Pubitemid 38017479)
9. Fox SB, Harris AL (2004) Histological quantitation of tumour angiogenesis. APMIS 112:413-430 (Pubitemid 39626050)
10. Gnepp DR (1993) Malignant mixed tumors of the salivary:glands a review. Pathol Annu 28:279-328
11. Gnepp DR, Brandwein MS, Henley JD (2000) Salivary and lacrimal glands. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck. W.B. Saunders, Philadelphia, pp 325-430
12. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70 (Pubitemid 30046295)
13. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94:883-893 (Pubitemid 34778087)
14. Korkolopoulou P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P, Thomas-Tsagli E, Davaris P (2001) Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch 438:6036-6611
15. Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P (2002) Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 28:57-66 (Pubitemid 34175513)
16. Laitakari J, Nayha V, Stenback F (2004) Size, shape, structure, and direction of angiogenesis in laryngeal tumour development. J Clin Pathol 57:394-401 (Pubitemid 38446258)
17. Lewis JE, Olsen KD, Sebo TJ (2001) Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 32:596-604 (Pubitemid 32601241)
18. Livolsi VA, Perzin KH (1977) Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 39:2209-2230
19. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O (2006) Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch 44:127-134 (Pubitemid 43237877)
20. Nathonson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413-423
21. Nguyen M, Lee MC, Wang JL, Tomlinson JS, Shao ZM, Alpaugh ML, Barsky SH (2000) The human myopithelial cell displays a multifaceted anti-angoigenic phenotype. Oncogene 19:3449-3459 (Pubitemid 30487442)
22. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter KC, Harris AL, Fox S, Buyse M, Pilotti S, Pierotti M, Rilke F (1997) Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1:1417-1423 (Pubitemid 27479772)
23. + system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate™, CSA, LABC and SABC techniques. J Clin Pathol 51:506-511
24. Sharma S, Sharma MC, Sarkar C (2005) Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 46:481-489 (Pubitemid 40632304)
25. Sternlicht MD, Barsky SH (1997) The myoepithelial defense: a host defense against cancer. Med Hypotheses 48:37-46 (Pubitemid 27072863)
26. Swelam W, Ida-Yonemochi H, Maruyama S, Ohshiro K, Cheng J, Saku T (2005) Vascular endothelial growth factor in salivary pleomorphic adenomas: one of the reasons for their poorly vascularized stroma. Virchows Arch 446:653-662 (Pubitemid 40922272)
27. Tanaka F, Otake Y, Yanagihara K, kawano Y, Miyahara R, Li M, Ishikawa S, Wada H (2003) Correlation between apoptotic index and angiogenesis in non-small cell lung cancer: comparison between CD105 and CD34 as a marker of angiogenesis. Lung Cancer 39:289-296 (Pubitemid 36279449)
28. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564-1579 (Pubitemid 34876495)
29. Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD (1993) A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer 54:363-370 (Pubitemid 23169671)
30. Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor kappa B, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11:7334-7743